Change in Task-related Oxygen Uptake After EBV Treatment

Recruiting Observational Study
COPD
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
20 (estimated)
Sponsor
University Medical Center Groningen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Rationale: Bronchoscopic lung volume reduction using endobronchial valves (EBV) has emerged as a viable treatment option for eligible patients with severe emphysema. In all studies conducted so far, exercise capacity has only been measured using the 6-minute walk distance test (6MWT). It is known that patients with COPD frequently experience problems during ADL, which can lead to avoidance of or c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patient is scheduled for a bronchoscopic lung volume treatment using Pulmonx Zephyr Endobronchial Valves; 2. Patient read, understood and signed the Informed Consent Form. Exclusion Criteria: 1\) Patients who cannot perform ADL activities without the use of Long Term Oxygen…
Contacts

Jorine E Hartman, PhD

0031503619194

j.hartman@umcg.nl

CONTACT

Marlies van DIjk, MD PhD

0031503619194

CONTACT